跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
李 易展
教授
腫瘤惡化卓越研究中心
生物醫學影像暨放射科學系
電話
02-2826-7189, 02-2826-7000 #5570
電子郵件
yjlee2
ym.edu
tw
h-index
h10-index
h5-index
1749
引文
27
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
662
引文
16
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
152
引文
7
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1996 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(80)
類似的個人檔案
(6)
指紋
查看啟用 Yi-Jang Lee 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Cofilin
100%
Radiosensitivity
70%
Cancer Cells
62%
Tumor
49%
Overexpression
41%
Glycated chitosan
41%
188Re-liposome
41%
Apoptosis
37%
Autophagy
34%
Breast Cancer
33%
188Re
30%
Radiation-induced Senescence
27%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
26%
NIR-II
26%
H1299
25%
DNA Damage
25%
MDM2 SNP309
25%
Sestrin2
25%
Head-and-neck Cancer
25%
Localized Surface Plasmon Resonance
24%
Cancer Stem Cells
23%
Polymer Dots
23%
Therapeutic Efficacy
22%
Senescence
21%
Securin
21%
Ionizing Radiation
21%
Thymidine Kinase
21%
Tumor Growth
21%
H1299 Cells
21%
Ultrabright
20%
Radiation Effects
20%
Small Animal
20%
Tumor-bearing Mice
19%
Radiotherapy
19%
Reporter Gene Imaging
19%
Acute Kidney Injury
19%
Semiconducting Polymer Dots
19%
P27Kip1
19%
Bioluminescence Imaging
18%
Molecular Imaging
18%
Human Non-small Cell Lung Cancer
18%
Non-small Cell Lung Cancer (NSCLC)
18%
Therapeutic Effect
18%
Synergistic Effect
18%
Survival Rate
17%
Bystander Effect
17%
P21Cip1
17%
Biodistribution
17%
Colorectal Cancer Cells
17%
DNA Damage Response
17%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
88%
Malignant Neoplasm
86%
Protein P53
52%
Tumor Model
44%
Rhenium 188
41%
Liposome
39%
Breast Cancer
35%
Chitosan
33%
Tumor Growth
31%
Colorectal Carcinoma
30%
Ionizing Radiation
25%
Breast Tumor
25%
Actin
22%
Combination Therapy
21%
Lung Cancer
19%
Non Small Cell Lung Cancer
19%
Nanoparticle
18%
Liver Cell Carcinoma
18%
Cofilin
17%
Metastasis
16%
Fisetin
16%
Ovary Cancer
16%
Cofilin 1
16%
Mouse Model
16%
Arsenite
16%
Head and Neck Cancer
16%
Alkylating Agent
16%
Arsenous Acid
16%
Biodistribution
15%
Cytotoxicity
14%
Head and Neck Squamous Cell Carcinoma
14%
Cytokine
13%
IC50
13%
Survival Rate
13%
Cytoprotective Agent
12%
Immunologic Adjuvant
11%
Drug Resistance
11%
Glioblastoma
10%
Securin
10%
Therapeutic Effect
10%
Mouth Squamous Cell Carcinoma
10%
Ultraviolet Irradiation
9%
Radiopharmaceutical Agent
9%
Dosimetry
9%
Cancer Model
9%
Lung Adenocarcinoma
9%
Carcinogenesis
9%
Antioxidant
8%
Clinical Study
8%
Flavonoid
8%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
98%
Cofilin 1
66%
Radiosensitivity
61%
P53
54%
Cofilin
48%
Signal Transduction
38%
Actin
37%
Upregulation
35%
Autophagy
33%
H1299
31%
Reporter Gene
27%
Genotyping
22%
DNA Repair
21%
Securin
20%
Human Alphaherpesvirus 1
18%
Bystander Effect
17%
Cell Cycle
17%
DNA Damage Response
17%
P21
17%
Arsenite
16%
Arsenic Trioxide
16%
Platelet-Derived Growth Factor Receptor
16%
MicroRNA
16%
Arsenous Acid
16%
Normal Human
16%
DNA Damage
15%
Actin Depolymerizing Factor
14%
Dynamics
14%
Protein Expression
14%
Tumor Progression
13%
Low Drug Dose
12%
Cytoskeleton
12%
Green Fluorescent Protein
11%
G1 Phase
11%
Drug Resistance
10%
Oxidative Stress
10%
Angiogenesis
10%
Hypoxia Inducible Factor 1
10%
Transactivation
9%
Transcription
9%
Thymidine Kinase
9%
Molecular Genetics
9%
Cell Invasion
9%
Animal Model
9%
STAT3
9%
Morphology
9%
Fibroblast
9%
Oncogene C Myc
9%
Cyclin-Dependent Kinase
9%
Gene Promoter
9%
